Concepedia

Pencho Georgiev

PG

20

Publications

1.4K

Citations

15

H-Index

2014

Active since

Affiliations

University Multipurpose Hospital for Active Treatment "Sveti Georgi"(Current)

Medical University Plovdiv

University Hospital St. Marina

Alnylam Pharmaceuticals (United States)

Queen Mary University of London

Pencho Georgiev is an author at University Multipurpose Hospital for Active Treatment "Sveti Georgi" specializing in hematology, pharmacotherapy, and medicine.

ORCID

Top concepts

Publications per year

2014–2024

20

Publications

20

Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy

John Pasi, Savita Rangarajan, Pencho Georgiev et al. · New England Journal of Medicine · 2017 · 345 citations · Full text

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

Heinz Gisslinger, Christoph Klade, Pencho Georgiev et al. · The Lancet Haematology · 2020 · 327 citations

, , +5

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

Maria Domenica Cappellini, Vip Viprakasit, Alì Taher et al. · New England Journal of Medicine · 2020 · 289 citations

Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort

John Pasi, Toshko Lissitchkov, Vasily Mamonov et al. · Journal of Thrombosis and Haemostasis · 2021 · 93 citations · Full text

<scp>PK</scp>‐guided personalized prophylaxis with Nuwiq<sup>®</sup> (human‐cl rh<scp>FVIII</scp>) in adults with severe haemophilia A

Toshko Lissitchkov, L. Rusen, Pencho Georgiev et al. · Haemophilia · 2017 · 51 citations · Full text

Rows per page

1–5 of 20